Article
T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.
Journal of clinical immunology - 1 Apr 2020
Heller Stephanie, Kölsch Uwe, Magg Thomas, Krüger Renate, Scheuern Andrea, Schneider Holm, Eichinger Anna, Wahn Volker, Unterwalder Nadine, Lorenz Myriam, Schwarz Klaus, Meisel Christian, Schulz Ansgar, Hauck Fabian, von Bernuth Horst
Abstract excerpt
PURPOSE: NEMO-deficient patients present with variable degrees of immunodeficiency. Accordingly, treatment ranges from antibiotic prophylaxis and/or IgG-substitution to allogenic hematopoietic stem cell transplantation (HSCT). The correct estimation of the immunodeficiency is essential to avoid over- as well as under-treatment. We compare the immunological phenotype of a NEMO-deficient patient with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
